Results 181 to 190 of about 106,039 (292)

Association Between High-Density Lipoprotein Characteristics and Hemostatic Parameters in the Netherlands Epidemiology of Obesity (NEO) Study-Brief Report. [PDF]

Arterioscler Thromb Vasc Biol
Yuan L, Han J, Cheng S, Rosendaal FR, Mook-Kanamori DO, Jukema JW, Vink H, van den Berg BM, Rabelink TJ, van Hylckama Vlieg A, Tietge UJF, Willems van Dijk K, Li-Gao R.   +12 more
europepmc   +1 more source

Clinical pharmacology consultations and their implementation in clinical decision making

British Journal of Clinical Pharmacology, EarlyView.
Aims One of the key roles of clinical pharmacologists is to work as consultants for other medical specialties. We wanted to investigate the characteristics of clinical pharmacology consultations, compare the types of consultations from different specialties, and evaluate how well the recommendations given were followed.
Mirjam Kauppila, Janne T. Backman, Outi Lapatto‐Reiniluoto   +2 more
wiley   +1 more source

Preclinical Evaluation of Colisorb: Surfactant-Free Hydrophilic Gelatin Sponge with Rapid Clotting and Enhanced Absorbency without Mechanical Compression. [PDF]

ACS Omega
Hassan M, Khalil EA, Halawa SA, Zagloul R, Abdel-Badiea E, Maher M, El-Sayed M, Sarhan WA, Abdellatif A.   +8 more
europepmc   +1 more source

Understanding the influence of transfusion and blood loss on tranexamic acid concentration in scoliosis surgery with blood loss

British Journal of Clinical Pharmacology, EarlyView.
Aims Tranexamic acid (TXA) stabilizes clot formation by inhibiting fibrin degradation and improves postoperative outcomes. However, rare adverse events (e.g., thrombosis, seizures) warrant dose–risk evaluation. This study examines how perioperative blood loss and transfusion practices affect TXA concentrations during paediatric scoliosis surgery ...
Paula Alexandra Sá, Luisa Barreiros, Marcela A. Segundo, Eugénia Cruz, Sibylle Langenecker   +4 more
wiley   +1 more source

Exploratory Analysis of Coagulation and Fibrinolysis Trajectories After IL-6 Antagonist Therapy in COVID-19: A Case Series. [PDF]

Biomedicines
Kovács EH, Rottler M, Ruszkai Z, Geréd C, Kiss T, Csata M, Réger B, Jakabfi-Csepregi R, Papp I, Turan C, Hegyi P, Fazakas J, Molnár Z, Tánczos K.   +13 more
europepmc   +1 more source

Trends and variation in the use of andexanet alfa for the reversal of direct oral anticoagulants in NHS trusts in England

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Andexanet alfa was recommended by the National Institute for Health and Clinical Excellence (NICE) as an option in the management of life‐threatening gastrointestinal bleeding in patients taking apixaban or rivaroxaban in May 2021. A recent UK‐wide survey of local hospital protocols for the use of andexanet alfa suggested that practice ...
Louis Fisher, Richard Buka, Rosalind Byrne, Stephen Black, Helen J. Curtis, Christopher Wood, Andrew Brown, Sebastian Bacon, Richard Croker, Ben Goldacre, Brian MacKenna, Victoria Speed   +11 more
wiley   +1 more source

Beyond hemostasis: a narrative review on the multifaceted therapeutic potential of Ankaferd Blood Stopper. [PDF]

Ann Med Surg (Lond)
Tibi SE, Nazir MH, Nazir S, Patel BD, Misra G, Patel T, Nasir F, Farhan M, Sardarova N, Anand N.   +9 more
europepmc   +1 more source

Optimizing biophysical properties of cellular niches to enhance stem cell‐derived extracellular vesicle function in musculoskeletal regeneration

BMEMat, EarlyView.
Extracellular vesicles (EVs) derived from stem cells show promise for applications in regenerative medicine, but their scalability and yield remain challenges. This review explores the approaches for biophysical modulations within cell niches on EV properties, discusses the current clinical application of EVs, and provides an outlook on the existing ...
Yang Xu, Chung Yin Matthew Cheung, Liling Liu, Hoi Pan Harry Cheung, Kam Yu Tam, Dai Fei Elmer Ker, Sarah H. Cartmell, Chuanbin Mao, Zhiyong Zhang, Dan Michelle Wang   +9 more
wiley   +1 more source

Successful hemodialysis initiation in acquired hemophilia a managed with susoctocog alfa and emicizumab. [PDF]

CEN Case Rep
Kihara A, Tamaki M, Sumitani R, Okinari C, Tada M, Miyakami S, Yamaguchi S, Inagaki T, Minato M, Shibata E, Hasegawa K, Wakino S.   +11 more
europepmc   +1 more source

Cutting edge strategies for diabetic wound care: Nanotechnology, bioengineering, and beyond

BMEMat, EarlyView.
Graphical abstract illustrates the challenges in diabetic wound healing, covering pathophysiology, formulation hurdles, and emerging therapeutic strategies. It highlights the role of hyperglycemia, formulation complexities, and advanced technologies like bioprinting and AI in improving diabetic wound management. Abstract Diabetic wounds affect millions
Usama Ahmad, Wan Nurhidayah Wan Hanaffi, Anas Islam, Aimen Salman, Mohd Muazzam Khan, Faiyaz Shakeel, Qiang Cai, Xiaojun Cai, Quazi T. H. Shubhra   +8 more
wiley   +1 more source